Skip to main content

Advertisement

Log in

Evaluation of co-existing diseases in children with familial Mediterranean fever

  • Comorbidities
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Familial Mediterranean fever (FMF) is A common periodic fever syndrome. The causative gene of the FMF is named Mediterranean Fever gene (MEFV). Increased inflammation in FMF may play a role as a trigger for the development of some diseases. The objective of the study is to evaluate the frequency of comorbid disorders in children followed up with diagnosis of FMF. Additionally, we aimed to assess the association between FMF and other inflammatory conditions in a large pediatric FMF cohort. A total of 686 FMF patients were included in the cross-sectional study. A questionnaire including questions about characteristics of fever episodes, presence of arthralgia, arthritis, abdominal pain, chest pain during and co-existence of any other disease diagnosed by a physician was filled out by face-to-face interviews with patients or their parents. Female–male ratio was 0.85. Median age at the time of study, age at disease onset and at the time of diagnosis were 12.9 (1.7–22.3), 3 (0.08–17), and 6 (0.75–17) years, respectively. In 130 (18.9%) FMF patients we detected co-existing inflammatory condition. The most common co-existing diseases were: juvenile idiopathic arthritis 42 (6.1%), asthma/reactive airway disease 29 (4.2%), Henoch–Schönlein purpura 20 (2.9%), uveitis 12 (1.7%) and inflammatory bowel disease 10 (1.4%). Except for asthma/reactive airway disease and inflammatory bowel disease, there was no significant difference regarding the type of MEFV gene mutation. We have reported increased frequencies of various inflammatory conditions and decreased frequency of asthma in patients with FMF.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Barut K, Sahin S, Adrovic A et al (2018) Familial Mediterranean fever in childhood: a single-center experience. Rheumatol Int 38(1):67–74

    CAS  PubMed  Google Scholar 

  2. Ozen S, Karaaslan Y, Ozdemir O et al (1998) Prevalence of juvenile chronic arthritis and familial Mediterranean fever in Turkey: a field study. J Rheumatol 25(12):2445–2449

    CAS  PubMed  Google Scholar 

  3. Bernot A, Clepet C, Dasilva C et al (1997) A candidate gene for familial Mediterranean fever. Nat Genet 17(1):25–31

    Google Scholar 

  4. Gangemi S, Manti S, Procopio V et al (2018) Lack of clear and univocal genotype–phenotype correlation in familial Mediterranean fever patients: a systematic review. Clin Genet 94(1):81–94

    CAS  PubMed  Google Scholar 

  5. Ozdogan H, Arısoy N, Kasapcopur O et al (1997) Vasculitis in familial Mediterranean fever. J Rheumatol 24(2):323–330

    CAS  PubMed  Google Scholar 

  6. Tunca M, Ozdogan H, Kasapcopur O et al (2005) Familial Mediterranean Fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine (Baltimore) 84(1):1–11

    Google Scholar 

  7. Barut K, Guler M, Sezen M, Kasapcopur O (2016) Increased frequency of psoriasis in the families of the children with familial Mediterranean fever. Clin Exp Rheumatol 34:137

    Google Scholar 

  8. Erden A, Batu ED, Seyhoglu E et al (2018) Increased psoriasis frequency in patients with familial Mediterranean fever. Ups J Med Sci 123(1):57–61

    PubMed  PubMed Central  Google Scholar 

  9. Ozer E, Seker D, Taner E et al (2018) The frequency of juvenile spondyloarthropathies in childhood familial Mediterranean fever. Clin Exp Rheumatol 36(Suppl. 115):141–145

    PubMed  Google Scholar 

  10. Yalcinkaya F, Ozen S, Ozcakar ZB et al (2009) A new set of criteria for the diagnosis of familial Mediterranean fever in childhood. Rheumatology 48(4):395–398

    PubMed  Google Scholar 

  11. Petty RE, Southwood TR, Manners P et al (2004) International League of Associations for Rheumatology Classification of Juvenile Idiopathic Arthritis: second revision, Edmonton, 2001. J Rheumatol 31(2):390–392

    PubMed  Google Scholar 

  12. Ozen S, Pistorio A, Iusan SM et al (2010) EULAR/PRINTO/PRES criteria for Henoch–Schonlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria. Ann Rheum Dis 69:798–806

    PubMed  Google Scholar 

  13. Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40(9):1725–1734

    CAS  PubMed  Google Scholar 

  14. Marshall GS, Edwards KM, Lawton AR (1989) Pfapa syndrome. Pediatr Infect Dis J 8:658–659

    CAS  PubMed  Google Scholar 

  15. Gewitz MH, Baltimore RS, Tani LY et al (2015) Revision of the Jones criteria for the diagnosis of acute rheumatic fever in the era of Doppler echocardiography a scientific statement from the American heart association. Circulation 131(20):1806–1818

    PubMed  Google Scholar 

  16. Newburger JW, Takahashi M, Gerber MA et al (2004) Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 110:2747–2771

    PubMed  Google Scholar 

  17. Koné-Paut I, Shahram F, Darce-bello M et al (2016) Consensus classification criteria for paediatric Behçet’s disease from a prospective observational cohort: PEDBD. Ann Rheum Dis 75:958–964

    PubMed  Google Scholar 

  18. Hentgen V, Grateau G, Kone-Paut I et al (2013) Evidence-based recommendations for the practical management of familial Mediterranean fever. Semin Arthritis Rheum 43:387–391

    PubMed  Google Scholar 

  19. Kisla Ekinci RM, Balci S, Altintas DU et al (2019) The influence of concomitant disorders on disease severity of familial Mediterranean fever in children. Arch Rheumatol 33(3):282–287

    Google Scholar 

  20. Ozcakar ZB, Cakar N, Uncu N et al (2017) Familial Mediterranean fever-associated diseases in children. QJM 110(5):287–290

    CAS  PubMed  Google Scholar 

  21. Pehlivan E, Adrovic A, Sahin S et al (2018) PFAPA syndrome in a population with endemic familial Mediterranean fever. J Pediatr 192:253–255

    PubMed  Google Scholar 

  22. Beser OF, Cokugras FC, Kutlu T et al (2014) Association of familial Mediterranean fever in Turkish children with inflammatory bowel disease. Turk Pediatri Ars 49:198–202

    PubMed  PubMed Central  Google Scholar 

  23. Berkun Y, Levy R, Hurwitz A et al (2011) The familial Mediterranean fever gene as a modifier of periodic fever, aphthous stomatitis, pharyngitis, and adenopathy syndrome. Semin Arthritis Rheum 40(5):467–472

    PubMed  Google Scholar 

  24. Cakir N, Pamuk ON, Dervis E et al (2012) The prevalences of some rheumatic diseases in western Turkey: Havsa study. Rheumatol Int 32:895–908

    PubMed  Google Scholar 

  25. Tozun N, Atug O, Imeryuz N et al (2009) Clinical characteristics of inflammatory bowel disease in Turkey: a multicenter epidemiologic survey. J Clin Gastroenterol 43:51–57

    PubMed  Google Scholar 

  26. Can G, Posul E, Yilmaz B et al (2018) Epidemiologic features of ınflammatory bowel disease in Western Blacksea region of Turkey for the last 10 years: retrospective cohort study. Korean J Intern Med 34:519–529

    PubMed  PubMed Central  Google Scholar 

  27. Aksu K, Keser G (2011) Coexistence of vasculitides with Familial Mediterranean Fever. Rheumatol Int 31:1263–1274

    PubMed  Google Scholar 

  28. Yalçınkaya F, Ozcakar ZB, Kasapcopur O et al (2007) Prevalence of the MEFV gene mutations in childhood polyarteritis nodosa. J Pediatr 151(6):675–678

    PubMed  Google Scholar 

  29. Can E, Yaprak ZK, Hamilcikan S, Erol M, Gayret OB, Yigit O (2018) MEFV gene mutations and clinical course in pediatric patients with Henoch–Schönlein purpura. Arch Argent Pediatr 116(3):e385–e391

    PubMed  Google Scholar 

  30. Mahr A, Guillevin L, Poissonnet M, Aymé S (2004) Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener’s granulomatosis, and Churg–Strauss syndrome in a French urban multiethnic population in 2000: a capture–recapture estimate. Arthritis Care Res (Hoboken) 51:92–99

    Google Scholar 

  31. Kasifoglu T, Calisir C, Cansu DU, Korkmaz C (2009) The frequency of sacroiliitis in familial Mediterranean fever and the role of HLA-B27 and MEFV mutations in the development of sacroiliitis. Clin Rheumatol 28(1):41–46

    PubMed  Google Scholar 

  32. Akar S, Soysal O, Balci A et al (2013) High prevalence of spondyloarthritis and ankylosing spondylitis among familial Mediterranean fever patients and their first-degree relatives: further evidence for the connection. Arthritis Res Ther 15:R21

    PubMed  PubMed Central  Google Scholar 

  33. Päivonsalo-Hietanen T, Tuominen J, Saari KM (2000) Uveitis in children: population-based study in Finland. Acta Ophthalmol Scand 78:84–88

    PubMed  Google Scholar 

  34. Köşker M, Çelikay O, Çalışkan S et al (2018) The association between uveitis and familial Mediterranean fever: coincidence or association? Turk Klin J Ophthalmol 27:249–254

    Google Scholar 

  35. Salehzadeh F, Yasrebi O, Hosseini Khotbesara M, Hosseini Khotbesara M et al (2014) Idiopathic uveitis and familial Mediterranean fever: is there any relationship? Autoimmune Dis 2014:238931

    PubMed  PubMed Central  Google Scholar 

  36. Güncan S, Bilge NS, Candu DÜ, Kaşifoğlu T, Korkmaz C (2016) The role of MEFV mutations in the concurrent disorders observed in patients with familial Mediterranean fever. Eur J Rheumatol 3:118–121

    PubMed  PubMed Central  Google Scholar 

  37. Schwartz T, Langevitz P, Zemer D, Gazit E, Pras M, Livneh A (2000) Behcet’s disease in Familial Mediterranean fever: characterization of the association between the two diseases. Semin Arthritis Rheum 29:286–295

    CAS  PubMed  Google Scholar 

  38. Yurdakul S, Gunaydin I, Tuzun Y et al (1988) The prevalence of Behcet’s syndrome in a rural area in northern Turkey. J Rheumatol 15:820–822

    CAS  PubMed  Google Scholar 

  39. Saraçlar Y, Sekerel BE, Kalayci O et al (1998) Prevalence of asthma symptoms in school children in Ankara, Turkey. Respir Med 92:203–207

    PubMed  Google Scholar 

  40. Oneş U, Sapan N, Somer A et al (1997) Prevalence of childhood asthma in Istanbul, Turkey. Allergy Eur J Allergy Clin Immunol 52:570–575

    Google Scholar 

  41. Kalyoncu AF, Selçuk ZT, Karakoca Y et al (1994) Prevalence of childhood asthma and allergic diseases in Ankara, Turkey. Allergy 49:485–488

    CAS  PubMed  Google Scholar 

  42. Sackesen C, Bakkaloglu A, Sekerel BE et al (2004) Decreased prevalence of atopy in paediatric patients with familial Mediterranean fever. Ann Rheum Dis 63:187–190

    CAS  PubMed  PubMed Central  Google Scholar 

  43. Bolat E, Arikoglu T, Sungur MA, Batmaz SB, Kuyucu S (2017) Prevalence and risk factors for wheezing and allergic diseases in preschool children: a perspective from the Mediterranean coast of Turkey. Allergol Immunopathol (Madr) 45:362–368

    CAS  Google Scholar 

  44. Brenner-Ullman A, Melzer-Ofir H, Daniels M, Shohat M (1994) Possible protection against asthma in heterozygotes for familial Mediterranean fever. Am J Med Genet 53:172–175

    CAS  PubMed  Google Scholar 

  45. Aydoğmuş Ç, Ayaz NA, Çakan M et al (2017) Is there any difference regarding atopy between children with familial Mediterranean fever and healthy controls? Allergol Immunopathol (Madr) 45:549–552

    Google Scholar 

  46. Aypar E, Ozen S, Okur H, Kutluk T, Besbas N, Bakkaloglu A (2003) Th1 Polarization in familial Mediterranean fever. J Rheumatol 30:2011–2013

    PubMed  Google Scholar 

  47. Simsek I, Pay S, Pekel A et al (2007) Serum proinflammatory cytokines directing T helper 1 polarization in patients with familial Mediterranean fever. Rheumatol Int 27:807–811

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

MY, AA, and OK contributed to the conception and design of the study, data analysis and manuscript writing. AA had substantial contribution to conception and design of the study and to data analysis. ET, KB, and MA contributed to data collection and data input. OK contributed to data analysis and manuscript writing. SS and KB contributed to data analysis and critical revisions. OK made final manuscript to be submitted for publication. All authors read and approved the final version of the manuscript.

Corresponding author

Correspondence to Ozgur Kasapcopur.

Ethics declarations

Conflict of interest

None of the authors of this paper has a conflict of interest, including specific financial interests, relationships and/or affiliations relevant to the subject matter or materials included.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yildiz, M., Adrovic, A., Tasdemir, E. et al. Evaluation of co-existing diseases in children with familial Mediterranean fever. Rheumatol Int 40, 57–64 (2020). https://doi.org/10.1007/s00296-019-04391-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-019-04391-9

Keywords

Navigation